Atlas Trials

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men

Clinical trial NCT04922424 · WITHDRAWN

Trial details

NCT number
NCT04922424
Sponsor
Yale University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionHyperlipidemias
Start date
2022-09-30
Primary completion
2023-08-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.